Who Paid My Doc
Medicare Part D drugs, by what Part D paid
3,159 drugs were dispensed to Medicare Part D patients in 2024. Each is a brand and generic name as CMS prints them, so one generic with several brands is several rows. Only prescribers with 11 or more claims of a drug are counted.
Part D drug cost
50 of 3,159- Eliquis Apixaban · brand $19,876,304,796 · 22,996,543 claims · 264,286 prescribers
- Ozempic Semaglutide · brand $12,375,986,475 · 9,930,484 claims · 171,191 prescribers
- Jardiance Empagliflozin · brand $10,678,957,372 · 10,654,599 claims · 198,275 prescribers
- Mounjaro Tirzepatide · brand $5,825,295,741 · 4,694,896 claims · 97,208 prescribers
- Xarelto Rivaroxaban · brand $5,436,701,739 · 5,888,827 claims · 134,291 prescribers
- Trelegy Ellipta Fluticasone/Umeclidin/Vilanter · brand $4,832,494,643 · 5,725,949 claims · 97,673 prescribers
- Trulicity Dulaglutide · brand $4,786,817,612 · 3,816,376 claims · 101,479 prescribers
- Farxiga Dapagliflozin Propanediol · brand $4,661,889,792 · 5,036,718 claims · 112,099 prescribers
- Humira(Cf) Pen Adalimumab · brand $3,795,159,532 · 437,072 claims · 11,704 prescribers
- Revlimid Lenalidomide · brand $3,788,009,700 · 217,318 claims · 5,780 prescribers
- Entresto Sacubitril/Valsartan · brand $3,480,046,730 · 3,384,891 claims · 62,054 prescribers
- Biktarvy Bictegrav/Emtricit/Tenofov Ala · brand $3,202,748,091 · 781,030 claims · 9,751 prescribers
- Januvia Sitagliptin Phosphate · brand $3,195,725,241 · 3,490,163 claims · 97,931 prescribers
- Xtandi Enzalutamide · brand $3,030,169,346 · 227,932 claims · 6,244 prescribers
- Vyndamax Tafamidis · brand $2,504,980,201 · 98,896 claims · 2,002 prescribers
- Lenalidomide generic $2,344,941,101 · 175,940 claims · 5,095 prescribers
- Stelara Ustekinumab · brand $2,252,981,771 · 85,101 claims · 3,145 prescribers
- Enbrel Sureclick Etanercept · brand $2,147,340,743 · 273,819 claims · 6,066 prescribers
- Imbruvica Ibrutinib · brand $1,965,538,197 · 127,477 claims · 4,797 prescribers
- Myrbetriq Mirabegron · brand $1,896,183,997 · 2,973,900 claims · 68,875 prescribers
- Ofev Nintedanib Esylate · brand $1,833,961,637 · 142,734 claims · 4,284 prescribers
- Pomalyst Pomalidomide · brand $1,738,046,814 · 79,949 claims · 2,972 prescribers
- Jakafi Ruxolitinib Phosphate · brand $1,735,227,944 · 109,580 claims · 3,945 prescribers
- Ibrance Palbociclib · brand $1,720,573,795 · 111,354 claims · 4,236 prescribers
- Invega Sustenna Paliperidone Palmitate · brand $1,665,583,552 · 551,596 claims · 14,010 prescribers
- Linzess Linaclotide · brand $1,572,673,940 · 2,056,032 claims · 57,702 prescribers
- Dupixent Pen Dupilumab · brand $1,547,122,325 · 390,688 claims · 13,112 prescribers
- Repatha Sureclick Evolocumab · brand $1,496,360,471 · 1,724,143 claims · 37,562 prescribers
- Ingrezza Valbenazine Tosylate · brand $1,470,001,392 · 195,113 claims · 8,413 prescribers
- Brukinsa Zanubrutinib · brand $1,460,269,190 · 110,650 claims · 3,905 prescribers
- Calquence Acalabrutinib Maleate · brand $1,431,537,798 · 103,061 claims · 3,960 prescribers
- Tagrisso Osimertinib Mesylate · brand $1,338,277,911 · 79,546 claims · 2,794 prescribers
- Rybelsus Semaglutide · brand $1,309,259,751 · 899,704 claims · 35,474 prescribers
- Opsumit Macitentan · brand $1,177,584,022 · 93,092 claims · 1,619 prescribers
- Erleada Apalutamide · brand $1,166,878,397 · 80,841 claims · 2,428 prescribers
- Rinvoq Upadacitinib · brand $1,124,402,419 · 161,517 claims · 4,982 prescribers
- Restasis Cyclosporine · brand $1,116,868,074 · 1,168,370 claims · 23,715 prescribers
- Breo Ellipta Fluticasone/Vilanterol · brand $1,072,696,267 · 2,102,473 claims · 63,483 prescribers
- Creon Lipase/Protease/Amylase · brand $1,014,341,252 · 521,133 claims · 17,565 prescribers
- Breztri Aerosphere Budesonide/Glycopyr/Formoterol · brand $912,446,611 · 1,165,471 claims · 29,313 prescribers
- Vraylar Cariprazine Hcl · brand $901,672,328 · 620,682 claims · 20,318 prescribers
- Skyrizi Pen Risankizumab-Rzaa · brand $848,218,895 · 40,889 claims · 2,203 prescribers
- Uptravi Selexipag · brand $829,774,604 · 36,269 claims · 889 prescribers
- Nubeqa Darolutamide · brand $828,748,991 · 64,907 claims · 1,944 prescribers
- Gemtesa Vibegron · brand $811,538,652 · 1,195,468 claims · 20,753 prescribers
- Austedo Deutetrabenazine · brand $797,237,770 · 121,191 claims · 5,194 prescribers
- Otezla Apremilast · brand $789,471,953 · 163,042 claims · 7,380 prescribers
- Verzenio Abemaciclib · brand $787,406,593 · 53,775 claims · 2,384 prescribers
- Tradjenta Linagliptin · brand $776,080,948 · 1,106,446 claims · 35,466 prescribers
- Xifaxan Rifaximin · brand $774,417,061 · 280,807 claims · 10,439 prescribers